Search results for

It's been a rough October for Donald Trump. Barring something extraordinary happening in the final few weeks, his path to win is a near-impossible feat to pull off.

An estimated 1.6 billion people — many of them in the developing world — pay bribes for public services, according to a new book. The alternative may be no health care and no education.

A rare exhibition at New York's Museum of Modern Art features 60 of Lawrence's paintings about the journey of 6 million African-Americans, who fled the segregated South during the Great Migration.

"Any successful lyricist has to be part playwright and has to be able to put himself into the minds and the hearts and the souls of the characters," Sheldon Harnick tells Fresh Air's Terry Gross.

Some 3,000 Afghan elders will assemble on Thursday in Kabul to consider a new security agreement with the U.S. The document will spell out the rules for American forces in Afghanistan troops after their combat mission ends in December 2014. U.S. officials say between 6,000 and 9,000 US troops would remain to train Afghan security forces and conduct counter-terror missions against al-Qaeda and other anti-government forces. That counter-terror mission remains a sticking point, though most other issues — like potential criminal liability of Americans in Afghanistan — have been resolved.

Host Rachel Martin gets the latest sports news from NPR's Mike Pesca. This week, they discuss a couple dubious baseball records.

The Federal Reserve is opening the door to possible interest rate hikes earlier next year than had been expected, as it wrestles with the highest inflation in nearly four decades.

The Federal Reserve is preparing to raise interest rates sooner and — perhaps — more aggressively after inflation reached the highest in nearly 40 years.

The 6-3 opinion, which was along ideological lines, invalidates provisions in 37 state constitutions that ban the direct or indirect use of taxpayer money in religious schools.

Food and Drug Administration has released Moderna's data supporting the company's claim that its pediatric vaccines appear to be safe and effective, including for children as young as six months old.